|
Tenazym
|
-
|
V/NRP/99/1034
|
Veyx-Pharma GmbH, Vācija
|
QJ01RV01
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Trypsin,Neomycin sulphate,Papain,Chymotrypsin,Prednisolone acetate,Tetracycline hydrochloridum
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
07-Aug-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 09112018LI (09-Nov-2018)
|
| Labelling text: |
[PDF] 09112018M (09-Nov-2018)
|
| Summary of product characteristics: |
[PDF] 09112018ZA (09-Nov-2018)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/99/1034-01 |
|
10 |
Injektors, 10 ml |
-
|
|